These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30775295)

  • 1. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
    Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
    Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
    Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
    J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
    Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
    Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
    Sinha S; Kar C; Das S; Dutta A; De A
    Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study.
    Gupta SK; Kumar KD
    Int J Pharm Investig; 2017; 7(4):193-197. PubMed ID: 29692979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
    Sharma R; Dogra D; Dogra N
    Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
    Belhekar MN; Taur SR; Munshi RP
    Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending Tertiary Care Hospital.
    Doshi K; Yegnanarayan R; Gokhale N
    Curr Drug Saf; 2016 Jul; ():. PubMed ID: 27457767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
    More SA; Atal S; Mishra PS
    J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions.
    Shukla AK; Jhaj R; Misra S; Ahmed SN; Nanda M; Chaudhary D
    J Family Med Prim Care; 2021 Sep; 10(9):3303-3308. PubMed ID: 34760748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Pattern and Causality Assessment of Drug-induced Cutaneous Reactions in a Tertiary Care Hospital in India: A Prospective Study.
    James J; Mohamed AB; Hussain FS; Rani J; Varadarajan S
    Curr Drug Saf; 2022; 17(3):193-198. PubMed ID: 34702154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
    Pandit S; Soni D; Krishnamurthy B; Belhekar MN
    J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Cutaneous Drug Reactions at a Rural-Based Tertiary Health-Care Center in Gujarat: An Eleven Year Study.
    Vora RV; Patel TB; Tandel JJ; Patel JK; Polra RV
    Indian Dermatol Online J; 2023; 14(1):50-54. PubMed ID: 36776185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
    Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
    Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous adverse drug reactions among people living with human immunodeficiency virus in a tertiary care hospital in Johor, Malaysia.
    Chua KY; Tey KE
    Int J STD AIDS; 2022 Aug; 33(9):812-820. PubMed ID: 35775121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous adverse drug reactions in Indian population: A systematic review.
    Patel TK; Thakkar SH; Sharma D
    Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Adverse Drug Reactions in a Tertiary Teaching Hospital: A Prospective, Observational Study.
    Jadhav A; Patil S; Manchanda I; Hasija R; Patil A
    Indian J Dermatol; 2021; 66(5):573. PubMed ID: 35068528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.